Provided by Tiger Trade Technology Pte. Ltd.

Genmab A/S

33.45
+0.04000.12%
Pre-market: 32.99-0.4600-1.38%05:43 EDT
Volume:2.54M
Turnover:85.08M
Market Cap:20.57B
PE:26.44
High:33.98
Open:33.36
Low:33.28
Close:33.41
52wk High:35.43
52wk Low:23.62
Shares:615.00M
Float Shares:604.00M
Volume Ratio:0.66
T/O Rate:0.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.27
EPS(LYR):1.54
ROE:14.00%
ROA:8.79%
PB:3.45
PE(LYR):21.76

Loading ...

Genmab Trial Setback: Terminated Melanoma Study Adds Uncertainty to GMAB’s Immuno-Oncology Outlook

TIPRANKS
·
Jun 12

Genmab Says Subgroup Data for Follicular Lymphoma Treatment Shows 'Sustained' Efficacy Benefits

MT Newswires Live
·
Jun 11

Genmab presents EPCORE FL-1 subgroup data at EHA 2026 Congress

TIPRANKS
·
Jun 11

Genmab A/S Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Jun 11

Genmab A/S Stock Rises Monday, Outperforms Market

Dow Jones
·
Jun 09

Genmab A/S Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Jun 04

Wells Fargo Gives a Buy Rating to Genmab (GMAB)

TIPRANKS
·
Jun 02

Genmab A/S Stock Falls Monday, Underperforms Market

Dow Jones
·
Jun 02

Genmab A/S Stock Falls Thursday, Underperforms Market

Dow Jones
·
May 29

Genmab assumed with a Buy at Truist

TIPRANKS
·
May 27

Genmab (GMAB) Has a New Rating from Truist Financial

TIPRANKS
·
May 27

Genmab : Truist Securities Assumes Coverage With Buy Rating; Target Price $40 VS $48

THOMSON REUTERS
·
May 27

Genmab A/S Stock Rises Tuesday, Outperforms Market

Dow Jones
·
May 27

Analysts Offer Insights on Healthcare Companies: Roivant Sciences (ROIV), Crescent Biopharma (CBIO) and Genmab (GMAB)

TIPRANKS
·
May 26

Wells Fargo Keeps Their Buy Rating on Genmab (GMAB)

TIPRANKS
·
May 26

Genmab A/S Stock Rises Friday, Underperforms Market

Dow Jones
·
May 23

Genmab A/S Stock Rises Wednesday, Outperforms Market

Dow Jones
·
May 21

Genmab A/S Stock Rises Monday, Outperforms Market

Dow Jones
·
May 19

Genmab A/S Stock Falls Wednesday, Underperforms Market

Dow Jones
·
May 14

Genmab A/S Stock Rises Monday, Outperforms Market

Dow Jones
·
May 12